ALKERMES | ALKS - Capitalização De Mercado





Capitalização De Mercado Alterar Data
AbbVie USD 435.86B 8.73B 2026-08
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
ALKERMES USD 7.93B 806M 2026-08
Amgen USD 209.65B 14.21B 2026-08
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 1.11T 18.32B 2026-08
Gilead Sciences USD 168.68B 11.82B 2026-08
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 611.36B 32.21B 2026-06
Malin Corporation EUR 133.52M 29.05M 2026-08
Merck USD 324.18B 6.81B 2026-08
Nektar Therapeutics USD 12.98B 10.86B 2026-08
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Otsuka Holdings JPY 5.87T 111.31B 2026-06
Ovoca Bio EUR 5.1M 3.93M 2026-08
Pfizer USD 143.89B 5.44B 2026-08
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Vertex Pharmaceuticals USD 121.59B 4.48B 2026-08